Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Exonhit discloses novel tubulin polymerization inhibitors

Jan. 3, 2012

Prima BioMed provides update on preclinical testing of Cripto-1 immunotherapy

Jan. 2, 2012

Clinical development ZP-1846 advances

Jan. 2, 2012

Clinical trial application submitted in Russia for AT-001

Jan. 2, 2012

Marshall Edwards raises funds to advance lead oncology candidates

Jan. 2, 2012

Apricus Biosciences finalizes acquisition

Jan. 2, 2012

Syndax Pharmaceuticals designs new azacitidine prodrugs

Jan. 2, 2012

New camptothecin derivatives designed in Spain

Jan. 2, 2012

New PAK-4 inhibitor under development to treat gastric cancers

Jan. 2, 2012

University of Colorado prepares new histone deacetylase inhibitors

Dec. 30, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...